Market Closed -
OTC Markets
13:30:00 25/03/2024 GMT
|
5-day change
|
1st Jan Change
|
0.000001
USD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
---|
Capitalization
1 |
15.87
|
3.072
|
10.45
|
Enterprise Value (EV)
1 |
16.09
|
3.435
|
9.45
|
P/E ratio
|
-0.27
x
|
-0.45
x
|
-2.02
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
2,878,344
x
|
2,121,960
x
|
2,809,650
x
|
EV / Revenue
|
2,916,868
x
|
2,373,049
x
|
2,540,035
x
|
EV / EBITDA
|
-3,290,035
x
|
-669,934
x
|
-3,500,921
x
|
EV / FCF
|
-3,632,015
x
|
-
|
13,336,539
x
|
FCF Yield
|
-0%
|
-
|
0%
|
Price to Book
|
5.24
x
|
-2.13
x
|
-6.78
x
|
Nbr of stocks (in thousands)
|
17,090
|
22,587
|
48,618
|
Reference price
2 |
0.9288
|
0.1360
|
0.2150
|
Announcement Date
|
30/09/19
|
15/01/21
|
02/11/21
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
|
-
|
2.473
|
5.515
|
1.448
|
3.72
|
EBITDA
|
-
|
-1.618
|
-4.889
|
-5.128
|
-2.699
|
EBIT
1 |
-0.8624
|
-1.628
|
-4.903
|
-5.17
|
-2.753
|
Operating Margin
|
-
|
-65.85%
|
-88.9%
|
-357.16%
|
-73.98%
|
Earnings before Tax (EBT)
1 |
-0.8624
|
-1.696
|
-6.693
|
-6.509
|
-3.134
|
Net income
1 |
-0.8624
|
-1.696
|
-6.693
|
-6.509
|
-3.151
|
Net margin
|
-
|
-68.6%
|
-121.36%
|
-449.63%
|
-84.69%
|
EPS
2 |
-0.9077
|
-1.880
|
-3.390
|
-0.3031
|
-0.1064
|
Free Cash Flow
|
-
|
-0.4513
|
-4.429
|
-
|
0.7086
|
FCF margin
|
-
|
-18.25%
|
-80.31%
|
-
|
19.05%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/02/19
|
01/02/19
|
30/09/19
|
15/01/21
|
02/11/21
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
-
|
0.06
|
0.21
|
0.36
|
-
|
Net Cash position
1 |
0.7
|
-
|
-
|
-
|
1
|
Leverage (Debt/EBITDA)
|
-
|
-0.0346
x
|
-0.0435
x
|
-0.0709
x
|
-
|
Free Cash Flow
|
-
|
-0.45
|
-4.43
|
-
|
0.71
|
ROE (net income / shareholders' equity)
|
-
|
-3,441%
|
-582%
|
-
|
210%
|
ROA (Net income/ Total Assets)
|
-
|
-166%
|
-127%
|
-
|
-93.7%
|
Assets
1 |
-
|
1.024
|
5.252
|
-
|
3.361
|
Book Value Per Share
2 |
0.1900
|
-0.1900
|
0.1800
|
-0.0600
|
-0.0300
|
Cash Flow per Share
2 |
0.1800
|
0.0200
|
0.0100
|
0
|
0.0300
|
Capex
1 |
0.09
|
0.03
|
0.03
|
-
|
-
|
Capex / Sales
|
-
|
1.11%
|
0.49%
|
-
|
-
|
Announcement Date
|
01/02/19
|
01/02/19
|
30/09/19
|
15/01/21
|
02/11/21
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 52 | | +42.69% | 750B | | +34.11% | 606B | | -6.87% | 356B | | +18.74% | 326B | | +6.76% | 286B | | +18.08% | 246B | | -3.44% | 213B | | +11.35% | 213B | | +2.64% | 167B |
Other Pharmaceuticals
|